PKM and neuroblastoma: Given that the expression of PKM and HK2 in neuroblastoma samples is strong predictors of negative clinical outcome, analysis of the protein content of circulating EVs could be used as a prognostic indicator and a non-invasive method for stratification of neuroblastoma patients.